Brilique 90 Mg 56 Tablets

Brilique 90 Mg 56 Tablets

Description:

Brilique 90 mg tablets are a prescription antiplatelet medicine (platelet aggregation inhibitor) containing ticagrelor, used to reduce the risk of heart attack, stroke, or cardiovascular death in patients with a history of acute coronary syndrome (such as heart attack or unstable angina) or established coronary artery disease. It works by preventing platelets in the blood from clumping together and forming harmful blood clots in the arteries. Brilique is typically used in combination with low-dose aspirin as directed by a cardiologist or healthcare professional.

Indications:

• Secondary prevention of atherothrombotic events (such as heart attack or stroke) in adult patients with acute coronary syndrome (ACS), including ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI), or unstable angina.
• Reduction of the risk of cardiovascular death, myocardial infarction, or stroke in patients with a history of myocardial infarction.
• Prevention of stent thrombosis in patients who have undergone percutaneous coronary intervention (PCI) with stent placement, when used with aspirin.
• Helps reduce the formation of blood clots in coronary arteries, which can lead to chest pain, heart attack, or stroke.

Active Ingredients / Key Components:

• Ticagrelor – 90 mg per film-coated tablet.
• Other tablet excipients (such as fillers, binders, and coating agents) are present but specific excipient names and concentrations , please check the product leaflet or the manufacturer’s official website. Refer to the official package leaflet for the full excipient list.

Dosage & Administration / How to Use:

• Brilique 90 mg tablets are for oral use in adults only and must be taken exactly as prescribed by your doctor.
• Typical regimen in acute coronary syndrome: usually 90 mg twice daily, used together with a daily maintenance dose of low-dose aspirin (75–150 mg), unless your doctor advises otherwise. The exact dose and duration are determined by your cardiologist.
• Swallow the tablet whole with a glass of water. It can be taken with or without food.
• Try to take the doses at the same times each day to maintain consistent blood levels.
• If you forget a dose, take the next dose at the usual time. Do not take a double dose to make up for a missed tablet.
• Do not stop taking Brilique without consulting your doctor, as stopping suddenly may increase your risk of heart attack or stroke.
• Use in combination therapy: Brilique is usually prescribed together with aspirin. Do not change the dose of aspirin or stop it unless instructed by your doctor.

Clinical Benefits:

• Helps prevent dangerous blood clots by inhibiting platelet aggregation, thereby reducing the risk of heart attack and stroke.
• Reduces the risk of cardiovascular death and recurrent myocardial infarction in patients with a history of acute coronary syndrome.
• Provides effective protection against stent thrombosis after coronary stent placement when used with aspirin.
• Offers rapid and reversible platelet inhibition, allowing more predictable control of antiplatelet effect compared to some other agents.

Warnings & Contraindications:

• Do not use Brilique if you are allergic (hypersensitive) to ticagrelor or any of the other ingredients in the tablets.
• Contraindicated in patients with active pathological bleeding (such as active peptic ulcer bleeding or intracranial hemorrhage).
• Contraindicated in patients with a history of intracranial hemorrhage.
• Contraindicated in severe hepatic (liver) impairment.
• Use with caution in patients at increased risk of bleeding, including those with recent trauma, recent surgery, coagulation disorders, or gastrointestinal ulcers.
• Inform your doctor if you have a history of asthma, chronic obstructive pulmonary disease (COPD), bradycardia (slow heart rate), heart rhythm disorders, or if you are taking medicines that affect heart rate.
• Tell your doctor and dentist that you are taking Brilique before any surgery, dental procedure, or new medication is started, as you may need to stop Brilique temporarily under medical supervision.
• Drug interactions: Use caution with strong CYP3A4 inhibitors or inducers, other anticoagulants, antiplatelet agents, NSAIDs, and certain heart medicines. Always inform your doctor about all medicines and supplements you are taking.
• Pregnancy and breastfeeding: Use only if clearly needed and prescribed by your doctor. Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding.
• Consult your doctor before use if pregnant, nursing, taking other medications, or if you have medical conditions such as liver disease, history of stroke, bleeding disorders, or kidney problems.
• Keep out of reach of children.
• This product is a prescription medicine and must be used under medical supervision.

Side Effects:

• Common side effects may include shortness of breath (dyspnea), dizziness, headache, nausea, diarrhea, and easy bruising or minor bleeding (such as nosebleeds or bleeding gums).
• Bleeding-related side effects can include prolonged bleeding from cuts, heavier or longer menstrual bleeding, or gastrointestinal bleeding (black or bloody stools, vomiting blood or material that looks like coffee grounds).
• Serious side effects may include severe or uncontrolled bleeding, signs of stroke (sudden weakness, difficulty speaking, vision changes), chest pain, irregular heartbeat, or severe shortness of breath.
• Stop the medication and seek immediate medical attention if you experience signs of severe bleeding, allergic reaction (rash, swelling of face or throat, difficulty breathing), or any sudden severe symptoms.
• This is not a complete list of side effects. Always read the patient information leaflet and consult your doctor or pharmacist if you notice any unusual symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the original packaging (refer to the leaflet or carton for exact storage conditions).

Specifications:

• Active ingredient: ticagrelor 90 mg per film-coated tablet.
• Form: film-coated tablets for oral use.
• Pack size: 56 tablets per pack.
• Intended for adult patients only, used under prescription and medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.